Develo Bags $14M to Rebuild Pediatric Practice Software Around AI

Los Angeles-based Develo has closed a $14 million funding round led by Blueprint Equity, with the fresh capital earmarked for expanding an AI-native operating system built specifically for pediatric healthcare practices.

The round also drew participation from Villain Capital, Z21 Ventures, and Bienville Capital, alongside a notable angel check from Paul Black, the former CEO of electronic health records giant Allscripts. His involvement signals a degree of validation from someone who spent years navigating the friction points of legacy medical software, the very problem Develo says it was founded to solve.

Founded in 2022, Develo has already found traction well beyond a pilot stage. The company's platform is currently running across hundreds of pediatric providers spread over more than 24 states, a footprint that suggests the product has moved past early adopters and into steady operational use in independent and group pediatric practices.

What the Platform Actually Does

Develo's pitch centers on collapsing several disconnected administrative workflows into a single AI-driven layer. The platform bundles an AI scribe that listens to and documents patient visits, automated charge capture to reduce billing leakage, and practice reporting intelligence that gives clinic operators visibility into performance metrics without manual spreadsheet work.

For pediatric practices, which often run on thinner margins and leaner administrative staff than adult primary care or specialty groups, that combination targets a real pain point: clinicians spending disproportionate time on documentation and billing rather than patient care. By framing the product as an "operating system" rather than a point solution, Develo is positioning itself against both traditional EHR incumbents and the wave of narrower AI scribe startups that have emerged over the past two years.

Why the Backers Matter

Sheldon Lewis, founding managing partner at Blueprint Equity, led the round, and Blueprint's healthcare-focused investment thesis aligns with Develo's vertical-specific approach rather than a horizontal, specialty-agnostic play. Dr. Aaron Sin, Develo's CEO and co-founder, brings a clinical background to the leadership team, a detail that matters in healthcare software where trust from practicing physicians often determines adoption speed more than feature lists.

Black's angel participation is arguably the most telling signal in the round. Having led Allscripts through the era when EHR systems became federally mandated infrastructure for American healthcare, he has direct experience with both the value and the frustration those systems generated among physicians. His backing suggests Develo's leadership sees an opening to correct some of that legacy friction specifically within pediatrics, a specialty that has historically been underserved by EHR vendors built primarily for adult and family medicine.

The $14 million infusion gives Develo runway to deepen its footprint in the 24-plus states where it already operates and likely to expand its AI feature set further into billing and clinical documentation, areas where automation continues to draw both investor enthusiasm and provider demand across healthcare technology broadly.